-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

908.O1.6 908. Outcomes Research: Myeloid Malignancies: Patient Reported Outcomes and their Association with Clinical Outcomes in Patients with Myeloid Malignancies

Symposia: Outcomes Research: Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, MDS, Adult, Clinical Practice (Health Services and Quality), APL, MPN, Epidemiology, Elderly, Clinical Research, Health outcomes research, Health disparities research, Chronic Myeloid Malignancies, Patient-reported outcomes, Diseases, Real-world evidence, Young adult , Myeloid Malignancies, Survivorship, Study Population, Human
Saturday, December 7, 2024: 4:00 PM-5:30 PM
Grand Hall B (Manchester Grand Hyatt San Diego)
Moderators:
Fernanda Seguro, MD, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, (HCFMUSP) and Alexander Coltoff, MD,
Disclosures:
No relevant conflicts of interest to declare.
4:00 PM

Nora Balas, PhD1*, Joshua Richman1*, Wendy Landier, PhD2*, Sadeep Shrestha, PhD3*, Katia J Bruxvoort, PhD3*, Lindsey Hageman, MPH1*, Qingrui Meng, MS2*, Elizabeth Ross3*, Alysia Bosworth, BA4*, Hok Sreng Te5*, F. Lennie Wong, PhD6, Ravi Bhatia, MD7, Stephen J. Forman, MD, FACP8, Saro Armenian, DO, MPH4, Daniel Weisdorf, MD5 and Smita Bhatia, MD, MPH1

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2University of Alabama At Birmingham, Birmingham, AL
3University of Alabama at Birmingham, Birmingham, AL
4City of Hope National Medical Center, Duarte, CA
5University of Minnesota, Minneapolis, MN
6City of Hope, Duarte, CA
7Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
8Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

4:15 PM

Fabio Efficace, PhD1*, Wael Al Essa2*, Uwe Platzbecker, MD3, Pasquale Niscola, MD4*, Giuseppe A Palumbo5*, Giovanni Caocci, MD6, Serena Puglia1*, Francesco Sparano1*, Massimo Breccia7*, Mario Luppi8*, Reinhard Stauder, MD, MSc9, Alessandra Ricco10*, Duska Petranovic11*, Frederic Baron12*, Maria Teresa Voso, MD13, Chiara Frairia, MD14*, Isabella Capodanno, MD15*, Chiara Sarlo16*, Rosangela Invernizzi17*, Claudio Fozza, MD18*, Maribel Doro19* and Marco Vignetti, MD1*

1Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy
2Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
3Clinic and Policlinic of Hematology and Cellular Therapy, Oncology and Hemostaseology, University Hospital, Leipzig, Germany
4Hematology Unit, Sant'Eugenio Hospital, Rome, Italy
5Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate “G.F. Ingrassia,” University of Catania, Catania, Italy
6University of Cagliari, Monserrato, Italy
7Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
8University of Modena and Reggio Emilia, AOU Modena, Modena, Italy
9Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
10Hematology and Transplants Unit, University of Bari, Bari, Italy
11Department of Hematology, Clinical Hospital Center Rijeka, Rijeka, HRV
12Department of Hematology, CHU de Liège, University of Liege, Liege, Belgium
13Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
14Department of Oncology, Division of Hematology, AOU Città della Salute e della Scienza, Turin, Italy
15Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
16Hematology and Stem Cell Transplantation Unit, University Campus Bio-Medico, Rome, Italy
17Department of Internal Medicine, San Matteo IRCCS Policlinic Foundation, University of Pavia, Pavia, Italy
18Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy
19Unidade de Hematologia, Hemoterapia e Oncologia (UHHO), Serviço de Transplante de Medula Óssea (STMO), Complexo Hospital de Clínicas da Universidade Federal do Paraná, Curitiba, Brazil

4:30 PM

Maria Queralt Salas, MD, PhD1*, Maria Teresa Solano2*, Mónica Baile González, MD3*, Marina Acera Gómez3*, Maria Laura Fox, MD4*, Maria del Mar Pérez Artigas4*, Ana Santamaria, MD5*, María del Carmen Quintela González5*, Andres Sanchez Salinas, MD6*, Joaquina Salmeron Camacho7*, Veronica Illana Álvaro8*, Zahra Abdallahi Lefdil8*, Sara Fernandez-Luis, MD9*, Leddy Patricia Vega Suárez9*, Javier Cornago, MD10*, Laura Pardo, MD10*, Sara Villar, MD11*, Patricia Beorlegui Murillo12*, Albert Esquirol, MD13*, Isabel Izquierdo, MD14*, Sonia González Rodriguez15*, Alberto Mussetti, MD16*, Esperanza Lavilla Rubira, MD17*, Javier López Marin, MD18*, Silvia Filafferro19*, Pascual Balsalobre20* and Ana Maria Sureda Balari, MD, PhD21

1Hematopoietic Transplantation Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
2Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
3Servicio de Hematología y Hemoterapia del Complejo Asistencial Universitario de Salamanca -IBSAL, Salamanca, Spain
4Vall d'Hebron University Hospital, Barcelona, Spain
5Hospital Álvaro Cunqueiro, Vigo, Spain
6Hematology Department, Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
7Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
8Hospital Universitario de la Princesa, Madrid, Spain
9Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
10Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
11Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
12Hematology and Cell Therapy Department, Clinica Universidad de Navarra, Navarra, Spain
13Hematology and Hemotherapy Department, Hospital de la Sant Creu i Sant Pau. IIB-Sant Pau and José Carreras Leukemia Research Institutes. Universitat Autónoma de Barcelona, Barcelona, Spain
14Hospital Universitario Miguel Servet, Zaragoza, Spain
15Institut Catala d’Oncologia-Hospitalet, Clinical Hematology Department, Barcelona, Spain
16Clinical Hematology Department, Institut Catala d’Oncologia-Hospitalet, L'Hospitalet De Llobregat, Barcelona, Spain
17Hospital Lucus Agusti, Lugo, Spain
18Hospital General de Alicante, Alicante, Spain
19Grupo EspañOl De Trasplante De Progenitores HematopoyéTicos Y Tera, Madrid, ESP
20Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC), Madrid, AL, Spain
21Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain

4:45 PM

Kirsi Manz, PhD1,2*, Florian H. Heidel, MD3, Steffen Koschmieder, MD4,5, Rudolf Schlag, MD6*, Joerg Lipke, MD7*, Frank Stegelmann, MD8*, Martin Griesshammer, Prof. Dr. med.9, Martine Klausmann10*, Carl Crodel11*, Andreas Hochhaus, MD12, Holger Schulz13*, Joachim R. Goethert, MD14, Haifa Kathrin Al-Ali, MD; PhD15,16*, Heiko Becker, MD17*, Andreas Reiter, MD18, Gernot Beutel, MD3*, Kim Kricheldorf19,20*, Tim H. H. Brummendorf, MD5,21, Wolfgang Hoffmann, MD1*, Konstanze Döhner, MD22 and Susanne Isfort23*

1Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
2Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, AL, Germany
3Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
4Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Aachen, Germany
5Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Faculty of Medicine, University Hospital RWTH Aachen, Aachen, Germany
6Practice for Hematology and Oncology Wuerzburg, Wuerzburg, Germany
7Practice for Hematology and Oncology, Dortmund, Cologne, Germany
8University Hospital of Ulm, Department of Internal Medicine III, Ulm, Germany
9University Clinic for Hematology, Oncology, Hemostasis and Palliative Care, Johannes Wesling Medical Center, University of Bochum, Minden, Germany
10Gemeinschaftspraxis Aschaffenburg, Aschaffenburg, Germany
11Department of Hematology and Oncology, Comprehensive Cancer Center Central Germany – Campus Jena, Jena University Hospital, Jena, Germany
12Hematology and Oncology, Comprehensive Cancer Center Central Germany – Campus Jena, Klinik für Innere Medizin II, Jena, Germany
13Oncological Practice, Frechen, DEU
14Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany
15Krukenberg Cancer Center Halle, Universitätsmedizin Halle, Halle (saale), Sachsony-anhalt, Germany
16Universitätsmedizin Halle, Halle, DEU
17Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
18Department of Hematology and Oncology, University Medical Centre Mannheim, Mannheim, Germany
19Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, University Hospital RWTH Aachen, Aachen, Germany
20Center for Integrated Oncology - Aachen Bonn Cologne Duesseldorf (CIO-ABCD), Aachen, Germany
21Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIOABCD), Aachen, Germany
22Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
23Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany

5:00 PM

Fabio Efficace, PhD1*, Adriano Venditti2, Thomas Baldi1*, Joanna Canham3*, Giovanni Martinelli, M.D.4, Alfonso Piciocchi, MS1,5*, Mike Dennis, MD, MRCP, FRCPath6, Steve Knapper, MRCP, FRCPath, DM7*, Nigel H. Russell, MD8, Sean Johnson3*, Maria Teresa Voso, MD9, Marco Vignetti, MD1* and Ian Thomas3*

1Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
2Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
3Centre for Trials Research, Cardiff University, Cardiff, United Kingdom
4IRCCS Istituto Scientifico Romagnolo per lo Studio dei Tumori "Dino Amadori" IRST S.r.l, Meldola, Italy
5GIMEMA Foundation, Rome, Italy
6The Christie NHS Foundation Trust, Manchester, United Kingdom
7School of Medicine, Cardiff University, Cardiff, United Kingdom
8Department of Haematology, Nottingham University Hospital, Nottingham, United Kingdom
9Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy

5:15 PM

Steve Dagenais-Bellefeuille, PhD1,2*, Karine Bilodeau, PhD3,4*, Alisa Poullet, MD1,2*, Shireen Sirhan, MD, FRCP5,6,7, Robert Delage, MD, MSc6,8, Ghislain Cournoyer, MD6,9, Ines Chamakhi, MD6,10, Danielle Talbot, MD6,11*, Luigina Mollica, MD, PhD2,4,6,12*, Daniele Marceau, MD6,13, Vincent Ethier, MD, BSc6,14, Pierre Desjardins, MD6,15*, Harold J. Olney1,6,16*, Michaël Harnois, MSc6*, Lambert Busque1,2,4,6* and Natasha Szuber, MD, MSc1,2,4,6

1University of Montreal, Montreal, QC, Canada
2Department of Hematology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
3Faculty of Nursing, University of Montreal, Montreal, QC, Canada
4Maisonneuve-Rosemont Hospital Research Centre, Montreal, QC, Canada
5Segal Cancer Center, Jewish General Hospital, Montreal, QC, Canada
6Quebec CML-MPN Research Group, Montreal, QC, Canada
7McGill University, Montreal, QC, Canada
8Integrated Cancer Center, CHU de Québec, Laval University, Quebec, QC, Canada
9Hemato-oncology, St-Jérôme Hospital, Saint-Jerome, QC, Canada
10Hemato-oncology, Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada
11Hemato-oncology, Cité-de-la-Santé Hospital, Laval, QC, Canada
12Université de Montréal, Montreal, QC, Canada
13Hemato-oncology, Hôtel-Dieu de Lévis, Quebec, QC, Canada
14Sherbrooke University Hospital Center (CHUS), Sherbrooke University, Sherbrooke, QC, Canada
15Hemato-oncology, Charles-Lemoyne Hospital, Sherbrooke University, Montreal, QC, Canada
16Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada

*signifies non-member of ASH